Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$20.78 - $31.77 $409,428 - $625,964
19,703 Added 21.29%
112,270 $3.52 Million
Q3 2023

Nov 08, 2023

SELL
$20.84 - $33.47 $195,541 - $314,049
-9,383 Reduced 9.2%
92,567 $1.93 Million
Q2 2023

Aug 02, 2023

SELL
$17.8 - $25.65 $364,757 - $525,619
-20,492 Reduced 16.74%
101,950 $2.44 Million
Q1 2023

Apr 26, 2023

SELL
$16.32 - $20.92 $536,030 - $687,117
-32,845 Reduced 21.15%
122,442 $2.3 Million
Q4 2022

Feb 01, 2023

BUY
$14.2 - $18.63 $143,036 - $187,659
10,073 Added 6.94%
155,287 $2.47 Million
Q3 2022

Oct 28, 2022

BUY
$14.11 - $18.27 $175,570 - $227,333
12,443 Added 9.37%
145,214 $2.38 Million
Q2 2022

Aug 04, 2022

BUY
$13.01 - $27.22 $470,038 - $983,431
36,129 Added 37.38%
132,771 $1.87 Million
Q1 2022

May 03, 2022

SELL
$20.94 - $27.5 $1.05 Million - $1.38 Million
-50,023 Reduced 34.11%
96,642 $2.34 Million
Q4 2021

Jan 31, 2022

SELL
$16.79 - $27.09 $276,363 - $445,901
-16,460 Reduced 10.09%
146,665 $3.42 Million
Q3 2021

Oct 27, 2021

BUY
$15.78 - $24.77 $739,892 - $1.16 Million
46,888 Added 40.34%
163,125 $2.71 Million
Q2 2021

Jul 23, 2021

BUY
$19.4 - $27.42 $718,537 - $1.02 Million
37,038 Added 46.77%
116,237 $2.84 Million
Q1 2021

Apr 27, 2021

SELL
$25.02 - $54.99 $65,952 - $144,953
-2,636 Reduced 3.22%
79,199 $2.04 Million
Q4 2020

Feb 03, 2021

SELL
$41.04 - $56.79 $155,377 - $215,006
-3,786 Reduced 4.42%
81,835 $4.38 Million
Q3 2020

Oct 27, 2020

SELL
$36.42 - $57.0 $3,569 - $5,586
-98 Reduced 0.11%
85,621 $3.53 Million
Q2 2020

Aug 04, 2020

BUY
$39.26 - $52.73 $239,250 - $321,336
6,094 Added 7.65%
85,719 $4.16 Million
Q4 2019

Jan 31, 2020

SELL
$36.21 - $51.4 $448,098 - $636,075
-12,375 Reduced 13.45%
79,625 $3.41 Million
Q3 2019

Oct 23, 2019

BUY
$22.22 - $44.01 $2.04 Million - $4.05 Million
92,000 New
92,000 $3.31 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.